Biotech Showcase 2021

Panel Discussion

The Anatomy of an Acquisition: Bayer and AskBio
Available On Demand

The acquisition of AskBio is a historical deal, not only because of the size of the deal, but also its strategic relevance. With Bayer consolidating its presence in the Cell and Gene Therapy space, partnering with AskBio presents a unique opportunity to lead the genomic medicine space. There are multiple elements that made this deal a success: record-breaking deal-making speed during a global pandemic, joint development of milestones that align interests, and a unique operating model that safeguards AskBio’s independence are just a few of the critical success factors.

Join AskBio CEO and co-founder Sheila Mikhail and Marianne De Backer, EVP, Head of Strategy, Business Development & Licensing and Executive Committee Member at Bayer AG Pharmaceuticals, for a fireside chat and learn more about the recent acquisition.

To register for Biotech Showcase Digital, visit